OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
August 16, 2006
Bioterrorism and larger profit margins could drive future growth.
Legal experts question how reverse payment deal went so awry.
Biotechs find sales more profitable than IPOs.